← Back to Patent Explorer
US4136160A Expired / Lapsed US ⏱️ 0.0 years remaining

Specific assay for active demyelinization

Assignee: Individual
•
Filing: 1977-08-17
•
Granted: 1979-01-23
•
Expires: 1997-08-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A specific test for active demyelinzation is based on a discovery that free myelin basic protein can be detected in cerebrospinal fluid by the use of a radioimmunoassay, and that the level of basic protein found corresponds to the activity of demyelinating pathologies. A simple method is utilized, wherein samples of cerebrospinal fluid are assayed and the results of the assay are compared with standard samples of myelin basic protein. Patients with active demyelinating diseases have high levels (17-100ng/ml) of basic protein; those with progressive pathologies have less (6-16 ng/ml); and those in remission have less than 4 ng/ml, comparable to the control population.

Inventors

  • 👤 Steven R. Cohen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 15:42
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6893; G01N33/6896; G01N2800/00; G01N2800/28; G01N2800/285; Y; Y10; Y10S; Y10S436/00; Y10S436/804; Y10S436/811

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 60 words
A method of conducting a specific assay for active demyelinization comprising the steps of incubating human spinal fluid with a radioactive antisera to myelin basic protein, addition of a known quantity of radioactive myelin basic protein to the inculation mixture, a separation of the bound and free basic protein, and measurement of the radioactivity of the bound and unbound fractions.
Claim 2
Independent Claim 60 words
A method of conducting a specific assay for active demyelinization comprising the steps of incubating human spinal fluid with a radioactive antisera to myelin basic protein, addition of a known quantity of radioactive myelin basic protein to the inculation mixture, a separation of the bound and free basic protein, and measurement of the radioactivity of the bound and unbound fractions.
Claim 3
Dependent Claim 16 words
The method claim 1 wherein said test is performed directly upon samples of unconcentrated cerebrospinal fluid.
Claim 4
Dependent Claim 16 words
The method of claim 1 wherein said test is performed upon concentrated samples of cerebrospinal fluid.
Claim 5
Dependent Claim 20 words
The method of claim 1 wherein said samples of cerebrospinal fluid are diluted with a buffer containing calf thymus histone.
Claim 6
Independent Claim 171 words
A method of detecting myelin basic protein in body fluids comprising the steps of: (a) withdrawing spinal fluid samples from the body; (b) adding Tris-acetate buffers to the fluid sample to achieve a concentration of 1 to 3 molar Tris-acetate in a pH range of pH 7.2 to pH 7.8, the buffer containing histone in the range of 1 to 20 mg. 1ml., and normal serum in the range of 0.25 to 1% and antisera in a concentration that gives 40% to 60% binding of the 125 I basic protein; (c) incubating the mixture for a period of time ranging from one to twenty-four hours at temperatures ranging from 37° C. to 4° C.; (d) adding 5,000 to 20,000 cpm. 125 I-labeled myelin basic protein to the mixture; (e) incubating this mixture for a period of time ranging from one to seventy-two hours at temperatures ranging from 4° C. to 37° C., forming an antibody-basic protein complex; (f) precipitating the antibody-basic protein complex in 0.3 to 0.7 ml. of cold ethanol;
Claim 7
Independent Claim 171 words
A method of detecting myelin basic protein in body fluids comprising the steps of: (a) withdrawing spinal fluid samples from the body; (b) adding Tris-acetate buffers to the fluid sample to achieve a concentration of 1 to 3 molar Tris-acetate in a pH range of pH 7.2 to pH 7.8, the buffer containing histone in the range of 1 to 20 mg. 1ml., and normal serum in the range of 0.25 to 1% and antisera in a concentration that gives 40% to 60% binding of the 125 I basic protein; (c) incubating the mixture for a period of time ranging from one to twenty-four hours at temperatures ranging from 37° C. to 4° C.; (d) adding 5,000 to 20,000 cpm. 125 I-labeled myelin basic protein to the mixture; (e) incubating this mixture for a period of time ranging from one to seventy-two hours at temperatures ranging from 4° C. to 37° C., forming an antibody-basic protein complex; (f) precipitating the antibody-basic protein complex in 0.3 to 0.7 ml. of cold ethanol;
Claim 8
Dependent Claim 26 words
(g) separating the antibody-basic protein complex from the supernant by centrifugation; and (h) assaying the antibody-basic protein complex and supernant for radiation using a radiation detector.
Claim 9
Dependent Claim 26 words
(g) separating the antibody-basic protein complex from the supernant by centrifugation; and (h) assaying the antibody-basic protein complex and supernant for radiation using a radiation detector.
Claim 10
Dependent Claim 48 words
The method described in claim 5 wherein 1 to 10 ml. of cerebrospinal fluid is lyophilized to dryness, 0.1 to 1.0 ml. of said buffer diluted tenfold is added to the dry material, and a 10 to 40 ul. aliquot is assayed following the steps of claim 5.
Claim 11
Dependent Claim 34 words
The method described in claim 5 wherein the precipitation step is performed by adding an antibody specific to rabbit gamma globulin, produced in any animal other than a rabbit, to the antibody-basic protein complex.
Claim 12
Dependent Claim 43 words
A mercantile unit comprising samples of Tris-acetate buffer containing histone and myelin basic protein antisera, said buffer having a pH in the range of 7.2 to 7.8, samples of I 125 -labeled myelin basic protein, and 0.3 to 0.7 ml. samples of ethanol.
Claim 13
Dependent Claim 43 words
A mercantile unit comprising samples of Tris-acetate buffer containing histone and myelin basic protein antisera, said buffer having a pH in the range of 7.2 to 7.8, samples of I 125 -labeled myelin basic protein, and 0.3 to 0.7 ml. samples of ethanol.
Claim 14
Dependent Claim 36 words
The merchantile unit claimed in claim 8 wherein samples of an antibody specific to rabbit gamma globulin produced in any animal other than a rabbit is substituted for the 0.3 to 0.7 ml. samples of ethanol.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-01-22 1982-07-24 1983-01-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-01-22 1986-07-24 1987-01-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-01-22 1990-07-24 1991-01-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag